Clinical Trial Update: Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating nucleos(t)ide analogues before peginterferon to increase sustained response in chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED